What is it about?
This review of published literature aims to explore the nonpharmacological management of infants at risk of neonatal abstinence syndrome in order to inform current practice and improve outcomes for this population. Consideration of multi-approach quality improvement projects, educational initiatives and single action directives such as rooming in.
Featured Image
Photo by Aditya Romansa on Unsplash
Why is it important?
Neonatal abstinence syndrome is a multisystem disorder resulting from exposure to maternal addictive substance use in pregnancy. Withdrawal is characterized by neonatal tremors, feeding difficulties, and sleep disruption which impact on clinical outcomes of the baby, interupts maternal and familial bondings and incurs health service costs. The aim of this review is to explore the nonpharmacological management of infants at risk of neonatal abstinence syndrome in order to inform current practice and improve outcomes for this population.
Perspectives
Systematic reveiw as part of the developement of a core outcome set for infants at risk of neonatal opioid withdrawal syndrome.
Dr Sonya MacVicar
Edinburgh Napier University
Read the Original
This page is a summary of: Systematic mixed‐study review of nonpharmacological management of neonatal abstinence syndrome, Birth, April 2019, Wiley,
DOI: 10.1111/birt.12427.
You can read the full text:
Contributors
The following have contributed to this page
